diabetestalk.net

Las Vegas Siblings Visit DC In Diabetes Research Funding Quest

Las Vegas siblings visit DC in diabetes research funding quest

Las Vegas siblings visit DC in diabetes research funding quest


Las Vegas siblings visit DC in diabetes research funding quest
Two Las Vegas siblings are in the nations capital to lobby for federal funding for research on Type 1 diabetes.
By Katelyn Umholtz Las Vegas Review-Journal
Siblings Oaklie, left, and Erick Leavitt are delegates on the Nevada Junior Diabetes Research Foundation. Photo taken on Wednesday, July 19, 2017, at the Leavitt's home, in Las Vegas. (Benjamin Hager/Las Vegas Review-Journal) @benjaminhphoto
Siblings Oaklie, left, and Erick Leavitt are delegates on the Nevada Junior Diabetes Research Foundation. Photo taken on Wednesday, July 19, 2017, at the Leavitt's home, in Las Vegas. Benjamin Hager Las Vegas Review-Journal @benjaminhphoto
Oaklie and Erick Leavitt both monitor their blood sugar level up to 6 times a day, and take insulin injections when necessary. Photo taken on Wednesday, July 19, 2017, at the Leavitt's home, in Las Vegas. (Benjamin Hager/Las Vegas Review-Journal) @benjaminhphoto
Siblings Erick, left, and Oaklie Leavitt are delegates on the Nevada Junior Diabetes Research Foundation. Photo taken on Wednesday, July 19, 2017, at the Leavitt's home, in Las Vegas. (Benjamin Hager/Las Vegas Review-Journal) @benjaminhphoto
Siblings Oaklie, left, and Erick Leavitt are delegates on the Nevada Junior Diabetes Research Foundation. Photo taken on Wednesday, July 19, 2017, at the Leavitt's home, in Las Vegas. (Benjamin Hager/Las Vegas Review-Journal) @benjaminhphoto
Oaklie and Erick Leavitt both monitor their blood sugar level up to 6 times a day, and take insulin injections when necessary. Photo taken on Continue reading

Rate this article
Total 1 ratings
One Drop Partners with Fitbit to Bring Diabetes Management Data Insights to Users Worldwide

One Drop Partners with Fitbit to Bring Diabetes Management Data Insights to Users Worldwide


One Drop Partners with Fitbit to Bring Diabetes Management Data Insights to Users Worldwide
One Drop users gain 24/7 access to Fitbit data in combination with One Drop health data to drive more comprehensive care management experience
One Drop to develop custom app for Fitbit Ionic providing diabetes-related health data on wrist for users of both Android and iOS devices
NEW YORK, Oct. 31, 2017 /PRNewswire/ -- One Drop, a leading digital diabetes care and self-management platform, today announced a multi-part collaboration with Fitbit (NYSE: FIT ) that will use the power of Fitbit wearable data to bring enhanced data-driven care management tools to the diabetes community. The first initiative will be to integrate enhanced access to Fitbit data into the One Drop | Mobile app for diabetes management, providing One Drop users with at-a-glance access to Fitbit data, with the goal of helping users better understand the impact of physical activity on blood glucose management. Fitbit data will also be incorporated into One Drop reports, allowing physicians and One Drop | Experts, and One Drop | Professional users to utilize this data to make more personalized, informed care decisions.
One Drop | Experts is the only digital diabetes education program accredited by the American Diabetes Association (PRNewsfoto/One Drop)
One Drop wireless blood glucose monitoring system with unlimited test strips (PRNewsfoto/One Drop)
Starting in November, One Drop users will be able to sync Fitbit intraday data to their One Drop accounts. This will allow users of the free, cloud-based diabete Continue reading

Saturated Fat for Diabetes

Saturated Fat for Diabetes


January 19, 2017 by David Mendosa
Did you think that saturated fat isnt good for your health? Actually it is both healthy and satisfying.
A new study by Norwegian researchers that The American Journal of Clinical Nutrition published at the end of November 2016 debunks the urban myth that you need to minimize how much saturated fat you eat. The researchers at the University of Bergen found strikingly similar health effects of diets based either on carbohydrates or on fats.
In their randomized controlled trial, 38 men with abdominal obesity followed diets that were high in either carbohydrates or fat, of which about half was saturated. The men in the study had normal fasting glucose.
Only the abstract of the study is online, but the corresponding author, Simon N. Dankel, Ph.D., sent me a copy of the full text. He is an assistant professor in the Department of Clinical Science at the University of Bergen.
I would especially like to draw your attention to the rigorous design of our study, Dr. Dankel said in an email. We matched the food types as well as energy (within normal range), protein, and polyunsaturated fatty acids, making for a more clear-cut comparison of carbs vs. fat.
The very high intake of total and saturated fat did not increase the calculated risk of cardiovascular diseases, said Ottar K. Nygrd, M.D., Ph.D., a professor in the Department of Clinical Science at the University of Bergan and cardiologist, in a press release from the university . He was a coauthor on the study.
Participants on the very high-fat diet also had substantial improveme Continue reading

The FreeStyle Libre, a device for monitoring blood sugar, is a pleasure to use.

The FreeStyle Libre, a device for monitoring blood sugar, is a pleasure to use.


Photo illustration by Slate. Photo by FreeStyle Libre.
In the years after I was diagnosed at 24 with Type 1 diabetes, I would sometimes cry when I stopped to study my hands. Back then, the skin of my fingertips was pockmarked by tiny craters, traces of the blood tests I performed seven or more times a day. Though they would heal in time, others would immediately take their place. Merely knowing they were there was dispiriting, a reminder that my disease would always leave its mark on my body in one way or another.
Successfully managing Type 1 diabetes requires almost relentless biomedical self-surveillance . You learn to count carbs, measure insulin doses, and track your glucose levels. Its the last of those thats the most frustrating for many who live with the disease, as the process has traditionally involved pricking your finger with a lancing device and then checking the capillary blood that springs forth. Typically, the process isnt that painful, but it can be messy, and the disposable single-use test strips it requires are often expensive, sometimes costing more than $1 each without insurance. (That may not sound like much, but it adds up if youre using them the recommended 48 times a day.) Perhaps more importantly, the information it reveals is limited, showing you where you stand in the moment but telling you nothing about whether your levels are rising, falling, or holding steady. That can be frustrating when you need it most, since it makes it hard to detect potentially dangerous rapid changes.
More recently, continuous glucose monitors (or CGMs) have begun t Continue reading

Eli Lilly Raises Insulin Prices While Supporting People With Diabetes

Eli Lilly Raises Insulin Prices While Supporting People With Diabetes


Although I was often called Goldilocks as a child, I never took a liking to the story. The little girl and I both had curly blond hair, but thats where the similarity ended. AboutLittle Red Riding Hood, however, I felt differently. As a child who happily made her way to grandmas all the time, Little Red Riding Hood and I shared a bond. Sure, she had to trek through a forest and all I had to do was cross over a little bayou bridge, but our destination was the same.
I attribute much of my lost childhood innocence to Little Red Riding Hood. Thanks to her story, I learned not only to worry about being gobbled alive or hacked up by a woodcutter, but to fear being tricked. Little Red alerted me to the possibility that in the bed where my loving, somewhat overbearing, tiny, white-haired, toothless grandmother slept, I could also encounter a hairy beast in a bonnet who wanted to eat me rather than feed me. And yesterday when I read that Eli Lilly, pharmaceutical giant, raised the price of their big selling insulins, Humalog and Humilin, by 7.8% just on the heels of a meeting with diabetes advocates to discuss the problem of the high cost of insulin, I couldnt help but think of Little Red Riding Hood and the deceiving wolf.
Exactly no one should be astonished that Lilly has, yet again, hiked the price of insulin. Its just another example of greedy pharma being greedy pharma. The escalation perfectly fits the pattern of insulin drugmakers regular price increases. (Its this pattern that led Senator Bernie Sanders toaskthe Department of Justice and the Federal Trade Commission to i Continue reading

No more pages to load

Popular Articles

Related Articles